A NOVEL THERAPEUTIC AGENT: EPT FUMARATE

Emerging as a promising candidate in the fight against malignancies, EPT Fumarate is gaining traction within the oncology community. This compounds possesses unique properties that disrupt vital functions within malignant growth, ultimately leading to inhibition of their growth. Studies have shown encouraging outcomes in preclinical settings, sugge